New medications development for smoking cessation
Authors:
Open Access
- 18 May 2023
- journal article
- research article
- Published by Elsevier in Addiction Neuroscience
- Vol. 7
Abstract
No abstract availableKeywords
This publication has 181 references indexed in Scilit:
- Bupropion Binds to Two Sites in theTorpedoNicotinic Acetylcholine Receptor Transmembrane Domain: A Photoaffinity Labeling Study with the Bupropion Analogue [125I]-SADU-3-72Biochemistry, 2012
- Withdrawal from Chronic Nicotine Exposure Alters Dopamine Signaling Dynamics in the Nucleus AccumbensBiological Psychiatry, 2012
- Blockade of Nicotine Reward and Reinstatement by Activation of Alpha-Type Peroxisome Proliferator-Activated ReceptorsBiological Psychiatry, 2011
- Both GABAB receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in ratsEuropean Journal of Pharmacology, 2011
- Habenular α5 nicotinic receptor subunit signalling controls nicotine intakeNature, 2011
- Repeated administration of the GABAB receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in ratsPsychopharmacology, 2010
- Peroxisome Proliferator-Activated Receptors-Alpha Modulate Dopamine Cell Activity Through Nicotinic ReceptorsBiological Psychiatry, 2010
- The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotinePsychopharmacology, 2010
- The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction studyDrug and Alcohol Dependence, 2009
- Tobacco/nicotine and endogenous brain opioidsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008